Deferred Tax Assets, Valuation Allowance of Cartesian Therapeutics, Inc. from 31 Dec 2015 to 31 Dec 2025

Taxonomy & unit
us-gaap: USD
Description
Amount of deferred tax assets for which it is more likely than not that a tax benefit will not be realized.
Summary
Cartesian Therapeutics, Inc. quarterly Deferred Tax Assets, Valuation Allowance in USD history and change rate from 31 Dec 2015 to 31 Dec 2025.
  • Cartesian Therapeutics, Inc. Deferred Tax Assets, Valuation Allowance for the quarter ending 31 Dec 2025 was $296,910,000, a 20% increase year-over-year.
Source SEC data
View on sec.gov
Deferred Tax Assets, Valuation Allowance, Quarterly (USD)
Deferred Tax Assets, Valuation Allowance, YoY Quarterly Change (%)

Cartesian Therapeutics, Inc. Quarterly Deferred Tax Assets, Valuation Allowance (USD)

Period Value YoY Chg Change % Date Report Filed Fiscal Year Fiscal Period
Q4 2025 $296,910,000 +$49,043,000 +20% 31 Dec 2025 10-K 09 Mar 2026 2025 FY
Q4 2024 $247,867,000 +$123,572,000 +99% 31 Dec 2024 10-K 09 Mar 2026 2025 FY
Q4 2023 $124,295,000 -$3,523,000 -2.8% 31 Dec 2023 10-K 13 Mar 2025 2024 FY
Q4 2022 $127,818,000 -$1,527,000 -1.2% 31 Dec 2022 10-K 07 Mar 2024 2023 FY
Q4 2021 $129,345,000 +$22,368,000 +21% 31 Dec 2021 10-K 02 Mar 2023 2022 FY
Q4 2020 $106,977,000 +$16,251,000 +18% 31 Dec 2020 10-K 10 Mar 2022 2021 FY
Q4 2019 $90,726,000 +$166,888,000 31 Dec 2019 10-K 12 Mar 2021 2020 FY
Q4 2018 $76,162,000 -$133,799,000 -232% 31 Dec 2018 10-K 12 Mar 2020 2019 FY
Q4 2017 $57,637,000 +$4,732,000 +8.9% 31 Dec 2017 10-K 15 Mar 2019 2018 Q4
Q4 2016 $52,905,000 +$14,405,000 +37% 31 Dec 2016 10-K 15 Mar 2018 2017 Q4
Q4 2015 $38,500,000 31 Dec 2015 10-K 28 Mar 2017 2016 FY
* An asterisk sign (*) next to the value indicates that the value is likely invalid.